CompoAtlas

Gemmothérapie Genévrier

Food supplement declared in France, decision dated 24 March 2025

Gemmothérapie Genévrier (LES SENS DE THEUS) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
LES SENS DE THEUS
Food business operator placing the product on the market
LES SENS DE THEUS
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Compte-gouttes
Daily dose
0.48
Directions for use
15 gouttes par jour à partir de 18 ans, avant les repas, en 3 prises. A diluer avec de l’eau. Cure de 10 à 21 jours.
Intended populations
Hommes et femmes de 18 ans et plus
Not recommended for (according to the manufacturer)
Adolescents (moins de 18 ans), Femmes allaitantes, Calculs rénaux, À prendre en dehors des repas, Enfants (moins de 12 ans), Enfants en bas âge (1 à 3 ans), Femmes enceintes, Insuffisance rénale, Maladie rénale, Nourrissons (moins de 1 an), Problèmes cardiaques, Enfants (de moins de 6 ans), Enfants (de moins de 10 ans)

Declaration 256670, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Juniperus communis L.Jeune pousseAutre macérât0.043 g

Other active ingredients

NamePer day
mielnot declared

Other ingredients

éthanol

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé aux femmes enceintes ou allaitantes Déconseillé en cas d’insuffisance cardiaque ou rénale œdémateuses, maladie rénale sévère, y compris néphrite interstitielle infectieuse, pyélite et pyélonéphrite Réservé aux adultes En cas de traitements médicamenteux, demander conseil à un professionnel de santé

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Juniperus communis L.
    Read the warning, when it applies and the studies cited

    Juniper - Juniperus Communis

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (Mills et al. 2006).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have a kidney disorder (Brinker 2010; Bradley 2006; ESCOP 2003; Hoffmann 2003).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 31 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : LES SENS DE THEUS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line